Editorial Commentary
Transdermal estradiol (tE2) as an alternative androgen deprivation therapy (ADT) in locally advanced prostate cancer
Translational Cancer Research
2026;
15
(7)
:513
.
(31 July 2026)
The evolution of cancer therapeutics: from “undruggable” to “drugged”
Translational Cancer Research
2026;
15
(7)
:514
.
(31 July 2026)
The significance of the 4Kscore in predicting medium- to long-term prostate cancer risk: insights from the European prospective investigation into cancer and nutrition
Translational Cancer Research
2026;
15
(7)
:515
.
(31 July 2026)
Next-generation sequencing-based high-risk genomic stratification in multiple myeloma
Translational Cancer Research
2026;
15
(7)
:516
.
(31 July 2026)
Dual target combination therapy demonstrates promise in extramedullary myeloma
Translational Cancer Research
2026;
15
(7)
:517
.
(31 July 2026)
Hepatitis C virus and extrahepatic malignancies: where we stand and how we can advance the field
Translational Cancer Research
2026;
15
(7)
:518
.
(31 July 2026)
Original Article
Development and external validation of a machine learning-based multimodal radiomics nomogram for predicting progression-free survival in triple-negative breast cancer
Translational Cancer Research
2026;
15
(7)
:519
.
(31 July 2026)
Garcinoic acid promotes ferroptosis-associated growth inhibition in esophageal squamous cell carcinoma through an MDM2-associated mechanism
Translational Cancer Research
2026;
15
(7)
:520
.
(31 July 2026)
Development and validation of a nomogram for predicting chemotherapy-induced liver injury in breast cancer patients
Translational Cancer Research
2026;
15
(7)
:521
.
(31 July 2026)
Prognostic value of gut microbiota-derived metabolites in non-small cell lung cancer: a retrospective cohort study of overall survival
Translational Cancer Research
2026;
15
(7)
:522
.
(31 July 2026)
High SRD5A2 expression is associated with poor prognosis and promotes tumor cell progression in colorectal cancer
Translational Cancer Research
2026;
15
(7)
:523
.
(31 July 2026)
An externally validated lactylation-associated prognostic signature for overall survival prediction in lung adenocarcinoma identifies TUBA1C as a candidate gene
Translational Cancer Research
2026;
15
(7)
:524
.
(31 July 2026)
Efficacy of nab-paclitaxel combined with immune checkpoint inhibitors in solid tumors: a systematic review and meta-analysis of randomized controlled trials
Translational Cancer Research
2026;
15
(7)
:525
.
(31 July 2026)
Development and validation of a multivariable CT-based Delta-radiomics model for predicting efficacy to bevacizumab therapy in patients with colorectal liver metastases
Translational Cancer Research
2026;
15
(7)
:526
.
(31 July 2026)
In vitro characterization of a novel anti-GD2/ROR1 bispecific antibody exhibiting tumor cell killing efficacy in neuroblastoma cross-cancer activity in ROR1-positive triple-negative breast cancer
Translational Cancer Research
2026;
15
(7)
:527
.
(31 July 2026)
The role of apparent diffusion coefficient histogram analysis in improving O-RADS magnetic resonance imaging classification of adnexal lesions: a retrospective diagnostic accuracy study
Translational Cancer Research
2026;
15
(7)
:528
.
(31 July 2026)
The impact of age on survival in stage II colon cancer: a SEER database analysis stratified by chemotherapy status
Translational Cancer Research
2026;
15
(7)
:529
.
(31 July 2026)
CKMT2 functions as a novel oncogenic gene in osteosarcoma, revealed by bioinformatics and experimental approaches
Translational Cancer Research
2026;
15
(7)
:530
.
(31 July 2026)
A weakly supervised deep learning model for OSCC diagnosis and lesion highlighting in histopathology images
Translational Cancer Research
2026;
15
(7)
:531
.
(31 July 2026)
PLAU accelerates extracellular matrix remodeling through partial epithelial-mesenchymal transition in head and neck squamous cell carcinoma
Translational Cancer Research
2026;
15
(7)
:532
.
(31 July 2026)
Elevated TARDBP expression correlates with an unfavorable prognosis, immune evasion, and poor immune efficacy in hepatocellular carcinoma
Translational Cancer Research
2026;
15
(7)
:533
.
(31 July 2026)
METTL17 promotes gastric cancer progression via inhibiting glycogen synthase kinase-3β to activate Wnt/β-catenin signaling
Translational Cancer Research
2026;
15
(7)
:534
.
(31 July 2026)
miR-506-5p targets MAPK7 to impede glioma growth and invasion through suppressing epithelial-mesenchymal transition and matrix metalloproteinases
Translational Cancer Research
2026;
15
(7)
:535
.
(31 July 2026)
Integrative analysis of HMGB3 in esophageal carcinoma: expression profile, prognostic significance, and immune microenvironment associations
Translational Cancer Research
2026;
15
(7)
:536
.
(31 July 2026)
Clinicopathological characteristics and prognosis of pulmonary spindle cell carcinoma: a population-based retrospective study using SEER data
Translational Cancer Research
2026;
15
(7)
:537
.
(31 July 2026)
A comparative analysis of clinical and sonographic features: cutaneous melanoma and melanocytic nevi
Translational Cancer Research
2026;
15
(7)
:538
.
(31 July 2026)
Clinical overall survival prediction and disease characteristics of locally advanced non-small cell lung cancer: an integrated analysis based on the SEER and TCGA databases
Translational Cancer Research
2026;
15
(7)
:539
.
(31 July 2026)
Feasibility study on the application of Raman spectroscopy in the diagnosis of glioma
Translational Cancer Research
2026;
15
(7)
:540
.
(31 July 2026)
HOXD9 prioritization within developmental regulator-related genes suggests stage-adjusted prognostic relevance in hepatocellular carcinoma
Translational Cancer Research
2026;
15
(7)
:541
.
(31 July 2026)
Interpretable machine learning prediction of 1-year overall survival in pancreatic cancer patients aged 65 years and older
Translational Cancer Research
2026;
15
(7)
:542
.
(31 July 2026)
TRIM47 promotes cell viability, cell cycle progression, metabolic reprogramming, and inhibits apoptosis of glioma via the NF-κB signaling pathway
Translational Cancer Research
2026;
15
(7)
:543
.
(31 July 2026)
A radiotherapy resistance-related prognostic signature predicts survival and the immune landscape in rectal cancer
Translational Cancer Research
2026;
15
(7)
:544
.
(31 July 2026)
PRSS1 promotes gastric cancer invasion and metastasis by induction of the epithelial-mesenchymal transition and activation of the MAPK/ERK pathway
Translational Cancer Research
2026;
15
(7)
:545
.
(31 July 2026)
Clinicopathological characteristics and prognosis of breast carcinoma with apocrine differentiation: a propensity score-matched analysis of the SEER database
Translational Cancer Research
2026;
15
(7)
:546
.
(31 July 2026)
Bergamottin demonstrates preclinical effectiveness against pancreatic cancer by modulating PPAR-γ to induce apoptosis
Translational Cancer Research
2026;
15
(7)
:547
.
(31 July 2026)
Hepatotoxicity of immune checkpoint inhibitor plus targeted therapy versus tyrosine kinase inhibitor monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(7)
:548
.
(31 July 2026)
TRIM32 drives head and neck squamous cell carcinoma progression via TP53 suppression and lysosomal/autophagy dysregulation
Translational Cancer Research
2026;
15
(7)
:549
.
(31 July 2026)
Differentiating breast cancer lung metastasis from primary lung cancer using clinical and computed tomography radiomics features
Translational Cancer Research
2026;
15
(7)
:550
.
(31 July 2026)
A multi-omics integration of bulk and single-cell transcriptomics identifies and validates a 16-gene epithelial-mesenchymal transition prognostic signature in tongue squamous cell carcinoma
Translational Cancer Research
2026;
15
(7)
:551
.
(31 July 2026)
A real-world cohort study reveals the treatment paradox of radiotherapy underuse despite its association with survival advantage
Translational Cancer Research
2026;
15
(7)
:552
.
(31 July 2026)
Bioinformatics-based identification of ferroptosis-related biomarkers and immune infiltration in retinoblastoma
Translational Cancer Research
2026;
15
(7)
:553
.
(31 July 2026)
Palmitoylation-related gene signature for immune subtyping, prognostic stratification, and immunotherapy guidance in hepatocellular carcinoma
Translational Cancer Research
2026;
15
(7)
:554
.
(31 July 2026)
ALOX12 suppresses colon cancer progression by promoting p53-mediated ferroptosis through upregulating ROS-induced stress
Translational Cancer Research
2026;
15
(7)
:555
.
(31 July 2026)
Construction of lactate-myeloid-related prognostic risk model and prediction of immune-excluded microenvironment in gastric cancer via integrated scRNA-Seq and bulk RNA-Seq
Translational Cancer Research
2026;
15
(7)
:556
.
(31 July 2026)
Osteoblast-specific factor 2 reduces glutathione by downregulating PRKRA expression in oral squamous cell carcinoma
Translational Cancer Research
2026;
15
(7)
:557
.
(31 July 2026)
Real-world retrospective cohort study of three conversion therapy regimens for unresectable locally advanced pancreatic cancer: a single-center 5-year analysis focused on conversion resection rate and survival outcomes
Translational Cancer Research
2026;
15
(7)
:558
.
(31 July 2026)
Adenylate cyclase 4 suppresses malignant progression of lung adenocarcinoma through interaction with protein kinase C beta
Translational Cancer Research
2026;
15
(7)
:559
.
(31 July 2026)
Elevated TMC8 expression correlates with CD8+ T cell infiltration and favorable survival in oral squamous cell carcinoma
Translational Cancer Research
2026;
15
(7)
:560
.
(31 July 2026)
Cysteine suppresses the progression of oral squamous cell carcinoma via regulating GLDC
Translational Cancer Research
2026;
15
(7)
:561
.
(31 July 2026)
Transcriptomic and experimental validation identify biomarkers and regulatory mechanisms associated with the aryl hydrocarbon receptor in nasopharyngeal carcinoma
Translational Cancer Research
2026;
15
(7)
:562
.
(31 July 2026)
Identification of prognostic risk factors and construction of nomograms for elderly patients with stage III–IV endometrioid endometrial carcinoma: a study based on the SEER database
Translational Cancer Research
2026;
15
(7)
:563
.
(31 July 2026)
KLF15-POU3F4 axis activates PI3K/AKT signaling to promote glioma progression
Translational Cancer Research
2026;
15
(7)
:564
.
(31 July 2026)
Matching-adjusted indirect comparison between asciminib and flumatinib as first-line treatment for chronic myeloid leukemia in China
Translational Cancer Research
2026;
15
(7)
:565
.
(31 July 2026)
Review Article
SLC16A3 links tumor metabolism to therapeutic opportunities in hepatocellular carcinoma
Translational Cancer Research
2026;
15
(7)
:566
.
(31 July 2026)
Emerging role of human epidermal growth factor 2-low status in the prognosis and management of triple-negative breast cancer: a narrative review
Translational Cancer Research
2026;
15
(7)
:567
.
(31 July 2026)
Case report
Sequential HER2-targeted antibody-drug conjugate therapy for acquired resistance in a 55-year-old male kidney transplant recipient with metastatic urothelial carcinoma: a case report
Translational Cancer Research
2026;
15
(7)
:568
.
(31 July 2026)
Precision de-escalation of immunotherapy in extensive-stage small cell lung cancer: a case report on ctDNA-guided management in a long-term survivor
Translational Cancer Research
2026;
15
(7)
:569
.
(31 July 2026)
Erratum
Erratum: Pathological features and biomarkers of hepatocellular carcinoma: a bibliometric analysis from 2005 to 2025
Translational Cancer Research
2026;
15
(7)
:570
.
(31 July 2026)
